Navigation Links
Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2
Date:3/13/2009

New York Stock Exchange Bell-Ringing, Yoko Ono Lennon Event at the UN, and "Walk on the Web" Highlight Global Autism Awareness Activities

New York, NY (PRWEB) March 13, 2009 -- Autism Speaks, the world's largest autism science and advocacy organization, today announced a series of national and international events to mark the second annual celebration of World Autism Awareness Day, a global effort to heighten awareness about a disorder affecting millions of individuals and families around the world. WAAD is a result of a resolution passed unanimously by the United Nations General Assembly in 2008, making autism one of only three health issues to be recognized by the UN with its own "day." The April 2 events will take place on multiple continents and in venues ranging from the floor of the New York Stock Exchange to the United Nations and the Worldwide Web.

Autism Speaks Co-Founders Bob and Suzanne Wright, together with Autism Speaks Board Member Alison Niederauer - who has a son on the autism spectrum and is the wife of NYSE Euronext CEO Duncan Niederauer - will join other families affected by autism to kick off World Autism Awareness Day (WAAD) at the New York Stock Exchange, where they will ring the opening bell for the second consecutive year.

"Last year's WAAD events were a remarkable success, and we are confident that the scope of this year's activities will help elevate autism as a topic of international discussion and exploration," said Suzanne Wright, co-founder of Autism Speaks. "On this day, we will highlight the tremendous contributions of individuals with autism, as well as the strength and dedication of their families. Together, we are inspiring compassion, inclusion and hope by building a global autism community whose voice is finally being heard."

Later that morning at the United Nations, artist Yoko Ono Lennon will
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Watch Me Learn Offers Schools a Teaching Solution for Children with Autism
2. Autism Support Network and the Israeli Society for Autistic Children Form International Alliance
3. Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month
4. UCI scientists to study brain region linked to autism, schizophrenia
5. Gene Variant Allies Autism, Gastrointestinal Woes
6. Talk About Curing Autism Launches Seven New Chapters
7. National Autism Association Announces American Legion Child Welfare Grant for Autism Outreach
8. On the Heels of Court Ruling Denying Autism-Vaccine Link, U.S. Federal Court Declares MMR Vaccine Caused Autism in a Young Boy
9. Lindt & Sprungli and Cookie Magazine Team up to Honor Lindt Unsung Heroes of Autism
10. ToysRUs and BabiesRUs Launch In-Store Fundraising Campaign to Benefit Autism Speaks
11. LENA Foundation Technology Measures Effectiveness of Autism Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:www.RightMedicare.com Launches to Offer Non-Biased Medicare Enrollment Assistance 2Health News:Mike Lucas of GE Healthcare Recognized as the Lifeline for Minority Businesses; Receives the MMBDC 2009 President's Award 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 2Health News:The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area 3Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 2Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 3Health News:Astronaut Balancing Act: Training to Help Explorers Adapt to a Return to Gravity 4
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 1Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 2Research Compares MENOPUR 28R 29 With rFSH in GnRH Antagonist IVF Cycles 5586 3Clues to Hypertension in Kids May Be Seen in Bones 59798 1Clues to Hypertension in Kids May Be Seen in Bones 59798 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3
Other Medicine Technology:Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6